The Oncology Insights Podcast - Daniel Varghese & Dr. Tony Abraham: Mobile Theranostics Access | Ep. 8

In this episode of The Oncology Insights Podcast, Dr. Abbie Begnaud speaks with Dr. Tony Abraham, President and Medical Director, and Daniel Varghese, CEO of RadiantPath Health, about advancing nuclear theranostics through mobile cancer care. They cover Lu-177 PSMA therapy, patient selection, regulatory hurdles, staffing challenges, and safety considerations. Daniel and Dr. Abraham also discusses how mobile delivery models can improve access for underserved communities and support earlier treatment. Listen now on all major platforms!

What you’ll learn: 

• Mobile theranostics access
• Community cancer delivery
• Lu-177 therapy
• Regulatory challenges
• Artificial intelligence planning

Meet the guests:

Daniel Varghese is a board-certified Physician Assistant and CEO of RadiantPath Health, leading the first mobile nuclear medicine unit in the United States.

Dr. Tony Abraham is a Nuclear Medicine Physician with fellowship training in PET/CT and nuclear oncology, and over 20 years of experience advancing targeted therapeutics in cancer care. 

Listen to The Oncology Insights Podcast to hear Daniel Varghese and Dr. Tony Abraham on all major platforms.
Connect with our guests on Social Media: Daniel Varghese & Dr. Tony Abraham

Liked this one? Don’t stop now. Here’s what we think you’ll love!